Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Foschi F. G
517  Ergebnisse:
Personensuche X
?
1

CXCL3 is a target of miR-30e-3p and predicts tumor escape i..:

Vianello, C. ; Leoni, I. ; Galvani, G....
Digestive and Liver Disease.  56 (2024)  - p. S94 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Long-term albumin administration improves survival in outpa..:

Zaccherini, G. ; De Venuto, C. ; Baldassarre, M....
Digestive and Liver Disease.  56 (2024)  - p. S65-S66 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Do ACE inhibitors have a role in preventing drug-related pr..:

Stefanini, B. ; Ielasi, L. ; Natola, L.A....
Digestive and Liver Disease.  56 (2024)  - p. S92 , 2024
Link: https://doi.org/10.1016/..
 
?
4

185P The combined role of patients (pts) gender and disease..:

Cesario, S. ; Genovesi, V. ; Rimini, M....
Annals of Oncology.  35 (2024)  - p. S83 , 2024
Link: https://doi.org/10.1016/..
 
?
5

MiR-22 regulates HIF-1A pathway and tumor progression and r..:

Galvani, G. ; Leoni, I. ; Monti, E....
Digestive and Liver Disease.  56 (2024)  - p. S96-S97 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Comparative analysis of subclassification models in patient..:

Ielasi, L. ; Stefanini, B. ; Conti, F....
Digestive and Liver Disease.  56 (2024)  - p. S85 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Role of P-shear wave hepatic elastography in prediction of ..:

Reggidori, N. ; Lazzari, M.L. ; Conti, F..
Digestive and Liver Disease.  56 (2024)  - p. S74 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Preoperative predictors of recurrence beyond Milan criteria..:

Pelizzaro, F. ; Trevisani, F. ; Vitale, A....
Digestive and Liver Disease.  55 (2023)  - p. S52-S53 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Outcomes of Sorafenib and Metronomic Capecitabine in Child-..:

Stefanini, B. ; Bucci, L. ; Santi, V....
Digestive and Liver Disease.  55 (2023)  - p. S222-S223 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Predictors of extrahepatic progression in patients with hep..:

Pinto, E. ; Pelizzaro, F. ; Vitale, A....
Digestive and Liver Disease.  55 (2023)  - p. S218 , 2023
Link: https://doi.org/10.1016/..
 
?
11

88P Adverse events (AEs) as potential predictive factors of..:

Persano, M. ; Rimini, M. ; Tada, T....
Immuno-Oncology and Technology.  20 (2023)  - p. 100560 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Lack of substantial improvements in the landscape of alcoho..:

Reggidori, N. ; Bucci, L. ; Santi, V....
Digestive and Liver Disease.  55 (2023)  - p. S16-S17 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Long-term albumin administration eases the management of hy..:

Zaccherini, G. ; Baldassarre, M. ; Tufoni, M....
Digestive and Liver Disease.  54 (2022)  - p. S40-S41 , 2022
Link: https://doi.org/10.1016/..
 
?
14

T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMAR..:

Giannini, E.G. ; Pieri, G. ; Labanca, S....
Digestive and Liver Disease.  54 (2022)  - p. S147-S148 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Atezolizumab plus bevacizumab versus lenvatinib or sorafeni..:

Rimini, M. ; Rimassa, L. ; Ueshima, K....
ESMO Open.  7 (2022)  6 - p. 100591 , 2022
Link: https://doi.org/10.1016/..
 
1-15